CANSINO BIOLOGICS INC
(HKEX: 6185)

CanSino Biologics, Inc. engages in the research and development, manufacturing, and sale of vaccines. It offers shingles, meningitis, polio, adenovirus, and tuberculosis vaccines. The company was founded by Xuan Liu, Xue Feng Yu, Tao Zhu, Dong Xu Qiu and Hui Hua Mao on January 13, 2009 and is headquartered in Tianjin, China.

38.300 -

-0.260 (-0.67%)
Range 37.900 - 38.720   (2.16%)
Open 38.720
Previous Close 38.560
Bid Price 38.040
Bid Volume ('000) 17.4
Ask Price 38.300
Ask Volume ('000) 7.4
Volume ('000) 480.2
Value 18,338,045
Remark -
Delayed prices. Updated at 05 Dec 2025 16:09.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis